TRAF2 and Hyperglycemia: These in-vitro findings strongly support the idea that maternal hyperglycemia inhibits fetal lung vasculogenesis in vivo by upregulating TRAF2-mediated GβL-ubiquitination and consequently promoting mTORC1 formation over mTORC2 formation.